Altrock, Eva https://orcid.org/0000-0002-2652-0958
Sens-Albert, Carla
Hofmann, Franziska
Riabov, Vladimir
Schmitt, Nanni
Xu, Qingyu
Jann, Johann-Christoph
Rapp, Felicitas https://orcid.org/0000-0003-0968-1546
Steiner, Laurenz
Streuer, Alexander
Nowak, Verena
Obländer, Julia
Weimer, Nadine
Palme, Iris
Göl, Melda
Darwich, Ali
Wuchter, Patrick
Metzgeroth, Georgia
Jawhar, Mohamad
Hofmann, Wolf-Karsten
Nowak, Daniel https://orcid.org/0000-0001-7130-7921
Funding for this research was provided by:
Hector Stiftung (M83)
Deutsche Forschungsgemeinschaft (No. 817/5-2, FOR2033, NICHEM)
Deutsche Krebshilfe (70113953)
Wilhelm Sander-Stiftung (2020.089.1)
Deutsches Rote Kreuz
Medizinische Fakultät Mannheim der Universität Heidelberg
Article History
Received: 3 June 2022
Accepted: 24 May 2023
First Online: 7 June 2023
Declarations
:
: The use of primary material followed written informed consent and approval by the Institutional Review Board of the Medical Faculty Mannheim, University of Heidelberg, Germany, in accordance with the Declaration of Helsinki. Approval number: 2013-509N-MA, title: Cell biological, animal experiments and molecular genetic studies of blood and bone marrow samples from patients with acute and chronic leukemia, myeloproliferative and myelodysplastic bone marrow diseases, date of approval 03/14/2019. All animal experiments were approved by the regional state authorities in Karlsruhe, Germany (G-150/17 Eltrombopag, date of approval 08/22/2017; G-291/19 HSC Expansion, date of approval 11/18/2019). All animal experiments were reported in compliance with the ARRIVE guidelines.
: Not applicable.
: The authors declare that they have no competing interests.